Literature DB >> 200827

Effect of polymyxin B on outer membranes of Serratia marcescens: morphological alterations of the outer membranes and their lipopolysaccharide components.

D A Weber, M J Nadakavukaren, J C Tsang.   

Abstract

The in vitro or the in vivo treatment of outer membranes and their lipopolysaccharide (LPS) components from Serratia marcescens with the antibiotic polymyxin B appeared to alter their normal morphology in a sequential manner. The normal spherodial morphology was destablized into a flattened structure after the in vitro treatment of either the resistant strain 08 or the sensitive strain Bizio. The more severe in vivo treatment of the outer membranes from the resistant strain converted the flattened forms further into spheres with undefined periphery and diminished sizes. On the other hand, the same treatment of the outer membranes from the sensitive strain resulted in numerous incomplete spheres and short rods, which were similar to the various morphological forms of the LPS components after polymyxin B treatment. The difference in the morphological changes of the outer membranes and their LPS components of the resistant and sensitive strains after polymyxin B treatment may be explained by the variation of the susceptiblity of the membrane components to the degradative effects of the antibiotic.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 200827

Source DB:  PubMed          Journal:  Microbios        ISSN: 0026-2633


  2 in total

1.  Lentivirus lytic peptide 1 perturbs both outer and inner membranes of Serratia marcescens.

Authors:  Shruti M Phadke; Vanja Lazarevic; Caroline C Bahr; Kazi Islam; Donna Beer Stolz; Simon Watkins; Sarah B Tencza; Hans J Vogel; Ronald C Montelaro; Timothy A Mietzner
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

2.  Outer membrane of Serratia marcescens: apparent molecular weights of heat-modifiable proteins in gels with different acrylamide concentrations.

Authors:  K B Heller
Journal:  J Bacteriol       Date:  1979-01       Impact factor: 3.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.